Posted by Michael Wonder on 04 May 2021
TGA approves new treatment for aggressive form of prostate cancer
5 May 2021 - The TGA has registered a new medication to treat a particularly aggressive and advanced type of prostate cancer.
Lynparza is manufactured by biopharmaceutical company AstraZeneca, and has for years been used to treat people with specific types of ovarian and breast cancer.
